Inhibition of PI3K improves contractility in alpha1-adrenergically stimulated myocardium

Frontiers in Bioscience

Volumn 13, Issue 18, 2008, Pages 6841-6849

  Jacobshagen, Claudius ^a   Kortlepel, Swantje ^a   Unsoeld, Bernhard W ^a   Sowa, Thomas ^a   Koegler, Harald ^a   Hasenfuss, Gerd ^a   Maier, Lars S ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Alpha1 adrenergic signaling; Calcium; Contractility; Heart failure; Phosphoinositide 3 kinase

Indexed keywords

ORYCTOLAGUS CUNICULUS;

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; HEART CONTRACTION; HEART VENTRICLE; MICROFILAMENT; MUSCLE CELL; PHYSIOLOGY; RABBIT; VASCULAR SMOOTH MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADRENERGIC ALPHA-AGONISTS; ANIMALS; CALCIUM; HEART VENTRICLES; MICROFILAMENTS; MUSCLE CELLS; MUSCLE FIBERS; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL CONTRACTION; RABBITS;

EID: 52049118268     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/3192     Document Type: Article

References (38)

1. M. P. Wymann, M. Zvelebil, M. Laffargue: Phosphoinositide 3-kinase signaling -which way to target? Trends Pharmacol Sci 24, 366-376 (2003) (Pubitemid 37315529)
2. G. Y. Oudit, H. Sun, B. G. Kerfant, M. A. Crackower, J. M. Penninger, P. H. Backx: The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 37, 449-471 (2004) (Pubitemid 38953373)
3. L. C. Cantley: The phosphoinositide 3-kinase pathway. Science 296, 1655-1657 (2002) (Pubitemid 34579158)
4. J. R. McMullen, T. Shioi, L. Zhang, O. Tarnavski, M. C. Sherwood, P. M. Kang, S. Izumo: Phosphoinositide 3-kinase(p110{alpha}) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Soc USA 100, 12355-12360 (2003) (Pubitemid 37271564)
5. J. R. McMullen, T. Shioi, W. Y. Huang, L. Zhang, O. Tarnavski, E. Bisping, M. Schinke, S. Kong, M. C. Sherwood, J. Brown, L. Riggi, P. M. Kang, S. Izumo: The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110{alpha}) pathway. J Biol Chem 279, 4782-4793 (2004) (Pubitemid 38199073)
6. T. Shioi, P. M. Kang, P. S. Douglas, J. Hampe, C. M. Yballe, J. Lawitts, L. C. Cantley, S. Izumo: The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19, 2537-2548 (2000) (Pubitemid 30323543)
7. B. DeBosch, I. Treskov, T. S. Lupu, C. Weinheimer, A. Kovacs, M. Courtois, A. J. Muslin. Akt1 is required for physiological cardiac growth. Circulation 113, 2097-2104 (2006)
8. I. Shiojima, K. Sato, Y. Izumiya, S. Schiekofer, M. Ito, R. Liao, W. S. Colucci, K. Walsh: Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115, 2108-2118 (2005) (Pubitemid 41134152)
9. T. Matsui, L. Li, J. C. Wu, S. A. Cook, T. Nagoshi, M. H. Picard, R. Liao, A. Rosenzweig: Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem 277, 22896-22901 (2002) (Pubitemid 34967272)
10. B. T. O'Neill, E. D. Abel: Akt1 in the cardiovascular system: friend or foe? J Clin Invest 115, 2059-2064 (2005) (Pubitemid 41134142)
11. D. D. Belke, S. Betuing, M. J. Tuttle, C. Graveleau, M. E. Young, M. Pham, D. Zhang, R. C. Cooksey, D. A. McClain, S. E. Litwin, H. Taegtmeyer, D. Severson, C. R. Kahn, E. D. Abel: Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 109, 629-639 (2002) (Pubitemid 34204842)
12. T. Doenst, H. Taegtmeyer: {alpha}-adrenergic stimulation mediates glucose uptake through phosphatidylinositol 3-kinase in rat heart. Circ Res 84, 467-474 (1999) (Pubitemid 29120013)
13. K. Yamashita, J. Kajstura, D. J. Discher, B. J. Wasserlauf, N. H. Bishopric, P. Anversa, K. A. Webster: Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1. Circ Res 88, 609-614 (2001) (Pubitemid 32275797)
14. E. Murphy, H. Tong, C. Steenbergen: Preconditioning: is the Akt-ion in the PI3K pathway? J Mol Cell Cardiol 35, 1021-1025 (2003) (Pubitemid 37083245)
15. R. Aikawa, M. Nawano, Y. Gu, H. Katagiri, T. Asano, W. Zhu, R. Nagai, I. Komuro: Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt. Circulation 102, 2873-2879 (2000)
16. N. Tanaka, T. Ryoke, M. Hongo, L. Mao, H. A. Rockman, R. G. Clark, J. Jr. Ross: Effects of growth hormone and IGF-I on cardiac hypertrophy and gene expression in mice. Am J Physiol Heart Circ Physiol 275, H393-H399 (1998)
17. M. A. Crackower, G. Y. Oudit, I. Kozieradzki, R. Sarao, H. Sun, T. Sasaki, E. Hirsch, A. Suzuki, T. Shioi, J. Irie-Sasaki: Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 110, 737-749 (2002) (Pubitemid 35283963)
18. Y. K. Kim, S. J. Kim, A. Yatani, Y. Huang, G. Castelli, D. E. Vatner, J. Liu, Q. Zhang, G. Diaz, R. Zieba, J. Thaisz, A. Drusco, C. Croce, J. Sadoshima, G. Condorelli, S. F. Vatner: Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt. J Biol Chem 278, 47622-47628 (2003) (Pubitemid 37523206)
19. M. V. G. Latronico, S. Costinean, M. L. Lavitrano, C. Peschle, G. Condorelli: Regulation of cell size and contractile function by AKT in cardiomyocytes. Ann NY Acad Sci 1015, 250-260 (2004) (Pubitemid 38879495)
20. 2+ currents via increased PI3K{alpha}/PKB signaling. Circ Res 98, 1390-1397 (2006) (Pubitemid 43948063)
21. K. D. Schluter, Y. Goldberg, G. Taimor, M. Schafer, H. M. Piper: Role of phosphatidylinositol 3-kinase activation in the hypertrophic growth of adult ventricular cardiomyocytes. Cardiovasc Res 40, 174-181 (1998) (Pubitemid 28435442)
22. 2+ handling: reduced SR Ca2+ load and activated SR Ca2+ release. Circ Res 92, 904-911 (2003) (Pubitemid 36542532)
23. M. Kohlhaas, T. Zhang, T. Seidler, D. Zibrova, N. Dybkova, A. Steen, S. Wagner, L. Chen, J. Heller Brown, D. M. Bers, L. S. Maier: Increased sarcoplasmic reticulum calcium leak but unaltered contractility by acute CaMKII overexpression in isolated rabbit cardiac myocytes. Circ Res 98, 235-244 (2006)
24. J. C. Kentish, H. E. ter Keurs, L. Ricciardi, J. J. Bucx, M. I. Noble: Comparison between the sarcomere lengthforce relations of intact and skinned trabeculae from rat right ventricle. Influence of calcium concentrations on these relations. Circ Res 58, 755-768 (1986) (Pubitemid 16094206)
25. C. Patton, S. Thompson, D. Epel: Some precautions in using chelators to buffer metals in biological solutions. Cell Calcium 35, 427-431 (2004) (Pubitemid 38379530)
26. E. Patrucco, A. Notte, L. Barberis, G. Selvetella, A. Maffei, M. Brancaccio, S. Marengo, G. Russo, O. Azzolino, S. D. Rybalkin, L. Silengo, F. Altruda, R. Wetzker, M. P. Wymann, G. Lembo, E. Hirsch: PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects. Cell 118, 375-387 (2004) (Pubitemid 39061117)
27. D. M. Bers, M. T. Ziolo: When is cAMP not cAMP?: effects of compartmentalization. Circ Res 89: 373-375 (2001) (Pubitemid 34132650)
28. K. R. Chien, J. Jr. Ross, M. Hoshijima: Calcium and heart failure: the cycle game. Nat Med 9, 508-509 (2003)
29. D. H. MacLennan, E. G. Kranias: Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4, 566-577 (2003) (Pubitemid 36773408)
30. 2+ oscillations in cardiac cells. J Cell Biol 152, 717-728 (2001)
31. G. Alloatti, R. Levi, D. Eel SL Malan, O. Bosco, L. Barberis, A. Marcantoni, I. Bedendi, C. Penna, O. Azzolino, F. Altruda, M. Wymann, E. Hirsch, G. Montrucchio: Phosphoinositide 3-kinase gamma-deficient hearts are protected from the PAF-dependent depression of cardiac contractility. Cardiovasc Res 60, 242-249 (2003) (Pubitemid 37412357)
32. S. Haq, G. Choukroun, H. Lim, K. M. Tymitz, F. del Monte, J. Gwathmey, L. Grazette, A. Michael, R. Hajjar, T. Force, J. D. Molkentin: Differential activation of signal transduction pathways in human hearts with hypertrophy versus advanced heart failure. Circulation 103, 670-677 (2001) (Pubitemid 32144195)
33. H. A. Baba, J. Stypmann, F. Grabellus, P. Kirchhof, A. Sokoll, M. Schafers, A. Takeda, M. J. Wilhelm, H. H. Scheld, N. Takeda, G. Breithardt, B. Levkau: Dynamic regulation of MEK/Erks and Akt/GSK-3beta in human endstage heart failure after left ventricular mechanical support: myocardial mechanotransduction-sensitivity as a possible molecular mechanism. Cardiovasc Res 59, 390-399 (2003) (Pubitemid 37272033)
34. H. A. Rockman, W. J. Koch, R. J. Lefkowitz: Seventransmembrane-spanning receptors and heart function. ature 415, 206-212 (2002)
35. M. A. Movsesian: Beta-adrenergic receptor agonists and cyclic nucleotide phosphodiesterase inhibitors: shifting the focus from inotropy to cyclic adenosine monophosphate. J Am Coll Cardiol 34, 318-324 (1999)
36. G. Y. Oudit, M. A. Crackower, U. Eriksson, R. Sarao, I. Kozieradzki, T. Sasaki, J. Irie-Sasaki, D. Gidrewicz, V. O. Rybin, T. Wada, S. F. Steinberg, P. H. Backx, J. M. Penninger: Phosphoinositide 3-kinase {gamma}-deficient mice are protected from isoproterenol-induced heart failure. Circulation 108, 2147-2152 (2003) (Pubitemid 37337593)
37. L. H. Young, Y. Ikeda, R. Scalia, A. M. Lefer: Wortmannin, a potent antineutrophil agent, exerts cardioprotective effects in myocardial ischemia/reperfusion. J Pharmacol Exp Ther 295, 37-43 (2000)
38. J. R. McMullen, F. Amirahmadi, E. A. Woodcock, M. Schinke-Braun, R. D. Bouwman, K. A. Hewitt, J. P. Mollica, L. Zhang, Y. Zhang, T. Shioi, A. Buerger, S. Izumo, P. Y. Jay, G. L. Jennings: Protective effects of exercise and phosphoinositide 3-kinase(p110{alpha}) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Soc USA 104, 612-617 (2007) (Pubitemid 46123073)